The neurological monitoring house says current half revenue - and earnings - have been slower than expected because of timing ...

As of Tuesday, December 09, Neumora Therapeutics, Inc.’s NMRA share price has dipped by 5.71%, which has investors questioning if this is right time to buy.

Monash University will today launch Victoria’s most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate breakthroughs in critical health challenges like ...

Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with FDA-supported analysis suggesting encouraging early signals.

Scientists found proof in the DNA of coffee drinkers connecting their daily drinking to a longer lifespan. They also found ...

Monash University will today launch Victoria's most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate ...

Bristol Myers Squibb moves forward with its ADEPT-2 study on Cobenfy, delaying data to next year but boosting investor ...

Class, Oral Synaptic Regenerative Investigational Therapy, Showed a Favorable Safety Profile and Promising Benefits in ...

Scientists found proof in the DNA of coffee drinkers connecting their daily drinking to a longer lifespan. They also found how much to drink to get benefits.

Bristol Myers jumps after choosing to continue its phase III ADEPT-2 study on Cobenfy for Alzheimer-related psychosis, delaying data to next year.

Because AI chatbots often respond in a sycophantic manner that can mirror and build upon users’ beliefs with little or no disagreement, Morrin said in an interview with Scientific American, the effect ...

A recent study suggests moderate coffee consumption may slow biological aging in people with mental disorders. Drinking three ...